Theravance Biopharma, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-014025 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014022 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-013997 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014000 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014005 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014009 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014015 | May 21, 2025 | May 19, 2025 |
| 4 | — | 0001415889-25-014017 | May 21, 2025 | May 19, 2025 |
| 8-K | FORM 8-K | 0001104659-25-051050 | May 20, 2025 | May 19, 2025 |
| 10-Q | 10-Q | 0001558370-25-007398 | May 12, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001104659-25-046137 | May 8, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002028 | Apr 30, 2025 | — |
| 4 | — | 0001415889-25-011227 | Apr 23, 2025 | Apr 21, 2025 |
| DEF 14A | FORM-DEF 14A | 0001104659-25-033819 | Apr 10, 2025 | May 19, 2025 |
| 10-K | 10-K | 0001558370-25-002447 | Mar 7, 2025 | Dec 31, 2024 |
| 4 | — | 0001415889-25-006684 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006668 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006670 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006675 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006679 | Mar 4, 2025 | Feb 28, 2025 |
| 8-K | FORM 8-K | 0001104659-25-017438 | Feb 26, 2025 | — |
| 4 | — | 0001415889-25-005353 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-005349 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-005357 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-005347 | Feb 24, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-005351 | Feb 24, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | — | 0001493152-25-006843 | Feb 14, 2025 | — |
| 4 | — | 0001415889-25-001957 | Jan 23, 2025 | Jan 21, 2025 |
| 144 | — | 0001950047-25-000341 | Jan 21, 2025 | — |
| 4 | — | 0001415889-24-027571 | Nov 22, 2024 | Nov 20, 2024 |
| 4 | — | 0001415889-24-027567 | Nov 22, 2024 | Nov 20, 2024 |
| 4 | — | 0001415889-24-027573 | Nov 22, 2024 | Nov 20, 2024 |
| 4 | — | 0001415889-24-027564 | Nov 22, 2024 | Nov 20, 2024 |
| 4 | — | 0001415889-24-027569 | Nov 22, 2024 | Nov 20, 2024 |
| 4 | — | 0001415889-24-027297 | Nov 19, 2024 | Nov 14, 2024 |
| 10-Q | 10-Q | 0001558370-24-015602 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0001013594-24-000953 | Nov 14, 2024 | — |
| 4 | — | 0001415889-24-026766 | Nov 13, 2024 | Nov 11, 2024 |
| SC 13G/A | — | 0000932471-24-001259 | Nov 12, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-116774 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000755 | Nov 4, 2024 | — |
| SC 13G/A | — | 0000932471-24-000692 | Nov 4, 2024 | — |
| SC 13G/A | — | 0002012383-24-002295 | Oct 24, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-101816 | Sep 23, 2024 | Sep 18, 2024 |
| 8-K | FORM 8-K | 0001104659-24-098326 | Sep 10, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-040632 | Sep 9, 2024 | — |
| 4 | — | 0001415889-24-022086 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022084 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022088 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022090 | Aug 22, 2024 | Aug 20, 2024 |